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Chromosomal aberrations, the consequence of refractory hyper- Hyperplasia of the parathyroid glands is a common
parathyroidism: Its relationship with biochemical parameters. secondary event that occurs in patients suffering chronic
Background. It has been shown that refractory hyperpara- renal failure. As a result of this, parathyroid hormonethyroidism (HPT) correlates biologically with a monoclonal
(PTH) secretion increases, causing clinical problems suchtrue neoplasm, but the chromosomal changes and their rela-
as hypercalcemia, bone disease, or nephrocalcinosis [1].tionship with biochemical variables such as high levels of phos-
phate, low levels of calcium (Ca), and calcitriol deficiency are In the late stage of this disease, the hyperparathyroidism
still in need of a deeper analysis. of some patients is almost autonomous and refractory,
Methods. Comparative genomic hybridization was used to
and the excessive PTH secretion no longer responds toscan for DNA copy number changes in two groups of samples:
biophysiologic influences or to aggressive medical treat-57 glands from refractory secondary HPT and 28 glands from
refractory HPT after kidney transplantation. Biochemical HPT- ment. Even after kidney transplantation, some patients
related parameters from these patients were collected and ana- do not recover and they can even develop hyperplastic
lyzed. growth, which affects the parathyroid glands with a simi-Results. Sixty-one percent of the glands from dialysis pa-
lar autonomous and non-responsive behavior.tients and 53.6% of the glands from transplanted patients suf-
Little is known about the genomic changes that mayfering severe secondary hyperparathyroidism had clonal chro-
mosomal imbalances. Losses were far more common than gains. take place in the parathyroid cells. It has been reported that
The most recurrent changes were losses of 1p (71%), monoso- the majority of surgically removed uremic parathyroid
mies of chromosomes 19 and 22 (45%), and losses of 20q (44%)
glands are monoclonal neoplasms, as assessed by X-chro-and 16p (42%). The most frequent gains were 5q, 6q, and 13q.
mosome-inactivation analysis [2–4]. Monoclonality sug-Biochemical parameters suggested that Ca excess is related to
the development of these chromosomal aberrations, although gests that genes involved in cell proliferation could be
it is not known if it is by playing a role in producing the mutated, with the final effect being the overgrowth of the
alterations or merely as a reflection of HPT severity. Phosphate glands. At this moment there are not any likely candidateslevels, despite their known effect in increasing the proliferation
for this phenomenon [5]. Few studies, without conclusiveof the parathyroid glands, were not related to the chromosomal
results, have been published with the purpose of identi-aberrations found in severe secondary HPT.
Conclusion. Clonal recurrent chromosomal changes are pres- fying chromosomal regions that may harbor putative para-
ent in more than half of the glands from patients with refractory thyroid tumor suppressor genes [6]. In an excellent recent
HPT, which undergo extreme biochemical levels in hyperpara-
report of 30 uremic patients with secondary or tertiary (re-thyroidism effectors. These changes support the idea of the
fractory) hyperparathyroidism, Imanishi et al [6] found, bymonoclonal neoplastic nature of this disorder.
using comparative genomic hybridization (CGH) and ge-
nome-wide allelotyping, that some chromosomal changes
and allelic losses were recurrent in their study.
We have conducted a blind retrospective CGH study
on two cohorts of samples from patients with secondary
Key words: genetic changes, renal failure, progression. hyperparathyroidism (HPT) and hyperparathyroidism
developed after kidney transplantation. CGH is a dou- 2003 by the International Society of Nephrology
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ble-color hybridization procedure that provides, in a sin- Grove, IL, USA). Equal amounts (1 g) of tumor and
normal reference DNA were co-precipitated with 15 ggle experiment, a general view of genomic monosomies
or amplifications within the tumor genome. Our purpose of unlabeled human Cot-1 DNA. Probe DNA was resus-
pended in 7 L of hybridization mixture (50 formamide,was to detect, if any, the nature of the genetic changes
involved in these two conditions and to compare the 2X SSC, 10 dextran sulfate) and hybridized to normal
human metaphase chromosomes slides commerciallychanges between both types of HPT.
The studies were complemented correlating the bio- available (Vysis, Inc.). Hybridization was performed at
37C for 48 hours. The slides were washed three times (5chemical data obtained from these patients during their
pre-dialysis, dialysis, and post-transplant (if they were minutes each) at 45C in 2X SSC, followed by three washes
(5 minutes each) at 45C in 0,1X SSC, and one wash (10transplanted) periods with the CGH results. High levels
of phosphate (P), low levels of calcium (Ca), parathyroid minutes) at 45C in 1X PBD. Slides were counterstained
with 4,6-diamino-2-phenylindole (DAPI) for the identi-hormone (PTH) and calcitriol deficiency are three of the
main effectors in secondary HPT genesis and progression fication of chromosomes.
[7], high P being a likely candidate for parathyroid gland
Digital image analysisgrowth and monoclonality-related autonomy apparition
due to irreversible structural and genetic changes [8]. The green and red fluorescence intensities of the hy-
bridization signals and the 4,6-diamino-2-phenylindoleThe aim of this portion of the study was to establish the
association between those parameters (P, Ca, and PTH) staining patterns were recorded with a cooled charge-
coupled device camera attached to a Nikon Eclipse 400and the presence of chromosomal alterations in parathy-
roid glands from hemodialysis patients. microscope (Nikon, Natick, MA, USA). Fluorescence
ratio profiles for each chromosome were calculated by
using the Quantitative Image Processing System (Vysis,
METHODS
Inc.). For each hybridization, the data from 10 to 14
Patients and samples representations of each chromosome were combined to
yield the mean and 95% confidence interval for thatWe studied 57 parathyroid glands corresponding to 22
dialysis patients with refractory secondary HPT, and 28 ratio, plotted next to the ideogram for that chromosome.
Gains or losses of chromosomes or chromosomal regionsglands from 13 kidney-transplanted patients with refrac-
tory HPT. DNA was phenol-chloroform extracted from were detected on the basis of ratio profile deviations
from the green/red balance value of 1.0. The upper andfrozen tissue in all instances according to standard proce-
dures. lower threshold limits for defining chromosomal gains
and losses were set at 1.20 and 0.80, respectively. These
Clinical data and statistics threshold values were determined in CGH experiments
using two differentially labeled, normal genomic DNAInformative biochemical data was obtained from 69
glands from 29 patients who underwent parathyroidec- samples. In these negative control experiments, the mean
green/red ratio was well within the range of 1.20 to 0.80tomy. The data obtained before the parathyroidectomy
were grouped according to values exceeding the normal for the entire length of all chromosomes, providing ro-
bust, highly stringent criteria for the determination ofrange (P5.5 and Ca10.5); maximum values for P, Ca,
and PTH were also considered. The statistical analysis gains and losses in tumor samples. Metaphase spreads
with uniform high-intensity fluorescence in both green(Mann-Whitney test) was performed considering the
glands independently or grouping them according to the and red colors on both homologous chromosomes, and
with no background spots, were selected for evaluations.patients; they were also grouped considering those pa-
tients/glands that had received a renal transplant before The centromeric and heterochromatic regions and p arm
of acrocentric chromosomes and telomeric regions werethe parathyroidectomy.
not included in the interpretation of gains and losses.
CGH
CGH was performed as described previously [9, 10].
RESULTS
Appropriated negative and positive controls were used
Chromosomal changes detected by CGHfor each experiment, and reverse labeling and fluores-
cence in situ hybridization (FISH) was performed in some Fifty-seven parathyroid glands from 22 dialysis pa-
tients with secondary HPT were analyzed by CGH. Thirty-samples to double-check our results. Standardized proto-
cols were used for labeling and competitive hybridiza- five glands (61%) demonstrated clonal chromosomal im-
balances that included both gains and losses of whole ortions. Briefly, the probe tumor DNA was labeled by stan-
dard nick-translation using fluorescein-12-deoxyuridine-5- partial chromosomes. Losses were far more common
than gains. The abnormal cases presented a mean of 3.7triphosphate. Texas Red commercially labeled normal
DNA was used as reference DNA (Vysis, Inc., Downers losses (range, 0–12) and of 1.2 gains (range, 0–10). The
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Table 1. Frequencies of the most recurrent chromosomal changes in refractory secondary hyperparathyroidism and after kidney
transplantation hyperplastic parathyroid glands
Frequencies of chrosomosomal losses % Frequencies of chrosomosomal gains %
Chromosome region Secondary HPT After transplantation HPT Chromosome region Secondary HPT After transplantation HPT
1p33–pter 71.4 73.3 4q22–q27 11.5 13.5
9q 22.9 6.6 5q11–q22 22.9 6.6
12q22–qter 17.1 26.6 6q12–q21 25.7 13.3
16p 42.9 20 12q13–q21 11.4 6.6





frequencies of each change, related to the number of Clinical associations
abnormal glands, are shown in Table 1. The chromo- Eighty percent of the patients with informative bio-
somal region 1p35-pter was the most common loss (71% chemical data available showed alterations in at least
of abnormal cases), followed by monosomies of chromo- one of the extracted glands. As can be seen in Figure 3,
somes 19 and 22 (45%), and losses of 20q (44%) and maximum values of calcium are significantly related to
16p (42%). As for gains, the most frequent were gains the presence of chromosomal aberrations, either when
of 5q, 6q, and 13q. The exact cytogenetic locations of counting glands or patients. The data have been consid-
the chromosomal changes are shown in Figure 1. Among ered in both ways because, although the glands from the
the abnormal glands, only 6 samples showed single changes. same patient are exposed to the same levels of P and
Ca, they could behave independently in their response.The remaining glands showed two or more changes. The
No significant differences were found regarding PTHsingle changes were: loss of 1p34-pter (in 3 cases), gain
levels or time on dialysis, perhaps due to the great vari-of complete chromosome 5 (2 cases), and loss of 3q26-
ability in the control and treatment of these patients.qter (1 case).
When considering the glands as independent values,Twenty-eight parathyroid glands from 13 kidney-trans-
maximum levels of P and also mean levels above theplanted patients with refractory HPT were analyzed by
normal range of P (markers of prolonged hyperphospha-CGH. Fifteen glands (53.6%) displayed genomic changes,
temia) have a significant inverse relationship with geneticincluding gains and losses. The abnormal cases presented
alterations detected by CGH. Thus, contrary to whata mean of 3.2 losses (range, 0–9) and a mean of 0.5 gains
was expected, maximum P and excess of P did not corre-(range, 0–2). The proportion of changes is also shown
late with the presence of chromosomal aberrations.in Table 1. The specific chromosome regions that were
The data was also subgrouped according to the pa-altered are shown in Figure 2. The chromosomal region
tients/glands that had received a kidney transplant be-1p33-pter was the most common loss (73% of abnormal
fore the parathyroidectomy. The same tendency was ob-cases) followed by losses of 20q (33%), monosomies 19
served in both batches of data, although only maximumand 22, and loss of 12q (26% of cases). As for gains, the
Ca and P were significantly different (the former in bothmost frequent were gains of 4q and 6q (13%). Among
glands and patients, not transplanted and transplanted,the abnormal glands, only 3 samples showed single changes,
respectively, and the latter in transplanted glands. Datathe remaining showing two or more changes. In those
not shown.)samples, the single genomic changes were: loss of 1p33-
pter (in 1 cases), gain of chromosome 5q (1 case), and
loss of 8q22-qter (1 case). DISCUSSION
Comparison of the frequencies of both set of patients Refractory hyperparathyroidism is a common event
(Table 1) revealed that the group with secondary HPT in long-term chronic renal failure. However, our knowl-
showed a slightly higher number of samples with chro- edge about the biological process that occurs within the
mosomal changes, but the difference was not statistically parathyroid glands of these patients is quite limited. The
significant (P  0.5). The type and relative frequency of first question about the nature of these disorders was to
the chromosomal aberrations were similar in both sets assess if it was a polyclonal expansion or a monoclonal
of samples. It is noteworthy that two abnormalities have neoplasm. It has been demonstrated by X-chromosome-
also been found as a unique change in both sets of sam- inactivation analysis [2–4, 11], that a large majority of
the patients with refractory hyperparathyroidism exhibitples: loss of 1p and gain of 5q.
Fig. 1. DNA copy number changes in 57 parathyroid glands from 22 patients with refractory secondary hyperparathyroidism. Each vertical bar
on the left side of each chromosome represents a loss in a particular gland and indicates the size and localization of the change. Each bar on the
right side of the chromosome represents a gain of DNA of that particular chromosome or chromosomal region.
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Fig. 2. DNA copy number changes in 28
parathyroid glands from 13 patients with re-
fractory hyperparathyroidism after kidney
transplantation. Each vertical bar on the left
side of each chromosome represents a loss in
a particular gland and indicates the size and
localization of the change. Each bar on the
right side of the chromosome represents a gain
of DNA of that particular chromosome or
chromosomal region.
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been reported previously, could be a hallmark of the
secondary HPT.
It is important to note that some chromosomal aberra-
tions were seen as unique changes in the samples. Loss
of 1p and gain of 5q were the most relevant. The fact
that these anomalies are the only change confers a puta-
tive role in the pathogenesis of the disease. More molecu-
lar work needs to be done to clarify the exact role of the
genes that are contained in those particular chromosome
regions.
Fig. 3. Relationship between the levels of P and Ca and the presence
The comparative CGH-biochemical portion of theor absence of chromosomal aberrations. (A) Glands considered inde-
pendently and (B) data grouped according to the patients. Light gray study suggests that Ca excess could be related to the
square  normal range of values for P. Dark gray square  normal development of chromosomal aberrations, although it is
range of values for Ca. *P  0.05
not known if it plays a role in producing chromosomal
alterations, or if it is merely a reflection of secondary
HPT severity. High phosphate levels, a well-known fac-
tor able to increase the proliferation of the parathyroida true neoplastic disorder. According to these observa-
glands, was not related to the rise of chromosomal aber-tions, a recent report [6] has shown that in a series of
rations found in severe secondary HPT in this study.46 parathyroid samples, 24% of them harbored one or
This could point out that the merging of chromosomalmore chromosomal changes detected by CGH. These
aberrations in secondary HPT is not due to the mereauthors also mentioned that the true number of mono-
proliferation increase by P levels, but to improper prolif-clonal tumors is likely to be much higher. In agreement
eration mechanisms triggered by still unknown factorswith this hypothesis, in our study of 85 samples, the
during the worsening of secondary hyperparathyroidism.proportion of cases with chromosomal changes was
Furthermore, the data shown here suggest that severityhigher (50%), probably reflecting the severe conditions
of the hyperplasia maybe not be equal to genetic damageof the patients with enriched monoclonal neoplasms [6].
in parathyroid glands. Further studies with a larger num-Technical overestimation of the chromosomal changes
ber of glands are needed to complete and validate thesewas ruled out by two means. First, we performed reverse
novel findings.CGH by labeling the reference and test DNA with the
opposite colors, in order to double-check the results.
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